Results 101 to 110 of about 76,246 (270)

LINC01116, a hypoxia‐lncRNA marker of pathological lymphangiogenesis and poor prognosis in lung adenocarcinoma

open access: yesMolecular Oncology, EarlyView.
The LINC01116 long noncoding RNA is induced by hypoxia and associated with poor prognosis and high recurrence rates in two cohorts of lung adenocarcinoma patients. Here, we demonstrate that besides its expression in cancer cells, LINC01116 is markedly expressed in lymphatic endothelial cells of the tumor stroma in which it participates in hypoxia ...
Marine Gautier‐Isola   +12 more
wiley   +1 more source

TOI-2015 b: A Warm Neptune with Transit Timing Variations Orbiting an Active Mid-type M Dwarf

open access: yesThe Astronomical Journal
We report the discovery of a close-in ( P _orb = 3.349 days) warm Neptune with clear transit timing variations (TTVs) orbiting the nearby ( d = 47.3 pc) active M4 star, TOI-2015.
Sinclaire E. Jones   +31 more
doaj   +1 more source

ATF4‐mediated stress response as a therapeutic vulnerability in chordoma

open access: yesMolecular Oncology, EarlyView.
We screened 5 chordoma cell lines against 100+ inhibitors of epigenetic and metabolic pathways and kinases and identified halofuginone, a tRNA synthetase inhibitor. Mechanistically halofuginone induces an integrated stress response, with eIF2alpha phosphorylation, activation of ATF4 and its target genes CHOP, ASNS, INHBE leading to cell death ...
Lucia Cottone   +11 more
wiley   +1 more source

Kepler-1624b Has No Significant Transit Timing Variations

open access: yesThe Astronomical Journal
It is relatively rare for gas giant planets to have resonant or near-resonant companions, but these systems are particularly useful for constraining planet formation and migration models. In this study, we examine Kepler-1624b, a sub-Saturn orbiting an M
Haedam Im   +11 more
doaj   +1 more source

Developing evidence‐based, cost‐effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities

open access: yesMolecular Oncology, EarlyView.
The cancer problem is increasing globally with projections up to the year 2050 showing unfavourable outcomes in terms of incidence and cancer‐related deaths. The main challenges are prevention, improved therapeutics resulting in increased cure rates and enhanced health‐related quality of life.
Ulrik Ringborg   +43 more
wiley   +1 more source

Modeling the Solar System. I. Characterization Limits from Analytic Timing Variations

open access: yesThe Planetary Science Journal
Planetary systems with multiple transiting planets are beneficial for understanding planet occurrence rates and system architectures. Although we have yet to find a solar system (SS) analog, future surveys may detect multiple terrestrial planets ...
Bethlee M. Lindor, Eric Agol
doaj   +1 more source

Cell surface interactome analysis identifies TSPAN4 as a negative regulator of PD‐L1 in melanoma

open access: yesMolecular Oncology, EarlyView.
Using cell surface proximity biotinylation, we identified tetraspanin TSPAN4 within the PD‐L1 interactome of melanoma cells. TSPAN4 negatively regulates PD‐L1 expression and lateral mobility by limiting its interaction with CMTM6 and promoting PD‐L1 degradation.
Guus A. Franken   +7 more
wiley   +1 more source

TESS Hunt for Young and Maturing Exoplanets (THYME). X. A Two-planet System in the 210 Myr MELANGE-5 Association

open access: yesThe Astronomical Journal
Young (
Pa Chia Thao   +37 more
doaj   +1 more source

APPLICATION OF TRANSIT TIMING VARIATION METHOD (TTV) TO EXOPLANET SYSTEM TrES-3

open access: yes, 2018
On the basis of the original photometricdata, the light curves of several transits in the exoplanet system TrES-3 were simulated by Monte Carlo method.Using these curves, the estimates of precise values of mid-transit time were calculated to assess the possibility offinding new planets by timing method in already known exoplanet systems using ground ...
openaire   +1 more source

Home - About - Disclaimer - Privacy